← Evidence map

TrialCancer science2012

Randomized phase II study of three doses of oral TAS-108 in postmenopausal patients with metastatic breast cancer.

Hideo Inaji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2012

2013

2014

2015

2016

2017

this papertrialcites it

Randomized phase II study of three doses of oral TAS-108 in postmenopausal patients with metastatic breast cancer. | OpenQuestion